Department of Health Sciences, Università del Piemonte Orientale, 28100, Novara, Italy.
Clin Exp Med. 2024 Oct 29;24(1):248. doi: 10.1007/s10238-024-01505-x.
Colorectal cancer (CRC) ranks among the most prevalent malignant tumors worldwide, with a multifactorial etiology encompassing genetic, environmental, and life-style factors, as well as the intestinal microbiota and its metabolome. These risk factors often work together in specific groups of patients, influencing how CRC develops and progresses. Importantly, alterations in the gut microbiota act as a critical nexus in this interplay, significantly affecting susceptibility to CRC. This review highlights recent insights into unmodifiable and modifiable risk factors for CRC and how they might interact with the gut microbiota and its metabolome. Understanding the mechanisms of these interactions will help us develop targeted, precision-medicine strategies that can adjust the composition of the gut microbiota to meet individual health needs, preventing or treating CRC more effectively.
结直肠癌(CRC)是全球最常见的恶性肿瘤之一,其病因具有多因素性,包括遗传、环境和生活方式因素,以及肠道微生物群及其代谢组。这些危险因素通常在特定患者群体中共同作用,影响 CRC 的发生和发展。重要的是,肠道微生物群的改变在这种相互作用中起着关键作用,显著影响 CRC 的易感性。本综述强调了结直肠癌不可改变和可改变的危险因素的最新见解,以及它们如何与肠道微生物群及其代谢组相互作用。了解这些相互作用的机制将有助于我们开发靶向、精准医学策略,通过调整肠道微生物群的组成来满足个体的健康需求,从而更有效地预防和治疗 CRC。